SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Indoco Remedies - Quaterly Results

17 May 2022 Evaluate
The Sales for the quarter ended March 2022 of Rs. 4088.80 millions rose by 34.12% from Rs. 3048.50 millions.Handsome Net Profit growth of 62.06% reported above the corresponding previous quarter figure of Rs. 403.70 millions to Rs. 249.10 millions.OP of the company witnessed a marginal growth to 807.60 millions from 565.40 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202203 202103 % Var 202203 202103 % Var 202203 202103 % Var
Sales 4088.80 3048.50 34.12 15397.20 12403.00 24.14 15397.20 12403.00 24.14
Other Income 2.90 19.70 -85.28 23.20 31.20 -25.64 23.20 31.20 -25.64
PBIDT 807.60 565.40 42.84 3293.20 2266.90 45.27 3293.20 2266.90 45.27
Interest 30.40 45.50 -33.19 141.40 222.20 -36.36 141.40 222.20 -36.36
PBDT 777.20 519.90 49.49 3151.80 2044.70 54.14 3151.80 2044.70 54.14
Depreciation 180.40 185.40 -2.70 789.50 731.20 7.97 789.50 731.20 7.97
PBT 596.80 334.50 78.42 2362.30 1313.50 79.85 2362.30 1313.50 79.85
TAX 193.10 85.40 126.11 817.10 389.60 109.73 817.10 389.60 109.73
Deferred Tax -45.20 96.40 -146.89 -115.20 4.90 -2451.02 -115.20 4.90 -2451.02
PAT 403.70 249.10 62.06 1545.20 923.90 67.25 1545.20 923.90 67.25
Equity 184.30 184.30 0.00 184.30 184.30 0.00 184.30 184.30 0.00
PBIDTM(%) 19.75 18.55 6.50 21.39 18.28 17.02 21.39 18.28 17.02

Indoco Remedies Share Price

228.20 -23.05 (-9.17%)
08-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1847.30
Dr. Reddys Lab 1293.25
Cipla 1347.70
Zydus Lifesciences 938.90
Lupin 2377.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×